HEPCVIR L SOFOSBUVIR AND LEDIPASVIR TABLETS

Get a Price/Quote

HEPCVIR L SOFOSBUVIR AND LEDIPASVIR TABLETS Specification

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
28 Tablets

Origin of Medicine
India

Indication
Chronic Hepatitis C Virus (HCV) infection

Expiration Date
24 to 36 months from manufacturing date

Grade
Pharmaceutical Grade

Salt Composition
Sofosbuvir and Ledipasvir

Usage
For the treatment of chronic hepatitis C infection

Medicine Type
Allopathic

Assay
Sofosbuvir 400 mg + Ledipasvir 90 mg

Dosage
One tablet daily or as directed by physician

Storage
Store below 30C, protected from moisture and light

CAS No
1190307-88-0 (Sofosbuvir); 1256388-51-8 (Ledipasvir)

Molecular Formula
Sofosbuvir: C22H29FN3O9P; Ledipasvir: C49H54N8O6

Appearance
Film-coated tablets

Shelf Life
2 to 3 years

Product Name
HEPCVIR L

Prescription Status
Prescription Only

Therapeutic Class
Antiviral agent

Intended Patient Population
Adults with genotype 1, 4, 5, or 6 HCV infection

Marketed In
India and export markets

Manufactured By
Cipla Ltd.

Administration Route
Oral

Packing Type
Bottle

Colour
Yellow to orange

Drug Class
NS5A inhibitor (ledipasvir) and nucleotide analog inhibitor (sofosbuvir)

HEPCVIR L SOFOSBUVIR AND LEDIPASVIR TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About HEPCVIR L SOFOSBUVIR AND LEDIPASVIR TABLETS

Hepcvir L Sofosbuvir & Ledipasvir

Specifications:

Brand Name : Hepcvir L
Content: Sofosbuvir and Ledipasvir
Strength: Sofosbuvir 400 mg & Ledipasvir 90 mg
Packing: 1X28 Tablets
Type: Tablets
Uses: Hepatitis C
Manufactured By : Cipla

Note :-Hepcvir L Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...............

Effective Antiviral Therapy for HCV

HEPCVIR L combines sofosbuvir and ledipasvir for a potent, targeted approach to treating chronic hepatitis C infection. This combination therapy blocks viral replication and significantly increases the chances of complete viral clearance, making it a reliable option for adult patients with specific HCV genotypes.

Convenient Dosage and Administration

HEPCVIR L comes in a bottle with 28 film-coated tablets. The recommended dosage is one tablet daily, taken orally, or as directed by your physician. The user-friendly, once-daily schedule helps support patient adherence throughout the treatment course, improving the likelihood of therapeutic success.

Quality and Safety Assured

Manufactured to pharmaceutical standards by Cipla Ltd., each batch of HEPCVIR L undergoes stringent quality control. With a shelf life of 2 to 3 years from manufacturing, the medicine retains its efficacy when stored properly. The formulation and packaging safeguard the stability of active ingredients.

FAQs of HEPCVIR L SOFOSBUVIR AND LEDIPASVIR TABLETS:

Q: How should HEPCVIR L be taken for optimal results?

A: HEPCVIR L should be taken exactly as prescribed by your healthcare provider, typically one tablet orally once a day. For best results, take the tablet at the same time each day and follow your physicians instructions closely throughout the treatment period.

Q: What medical condition is HEPCVIR L used to treat?

A: HEPCVIR L is intended for the treatment of chronic hepatitis C virus (HCV) infection in adults, specifically for patients with genotypes 1, 4, 5, or 6.

Q: When should I start seeing the effects of HEPCVIR L?

A: The timeline for improvement varies, but viral load reductions are often observed after several weeks of daily administration. Full course duration and monitoring will be determined by your doctor based on your individual response.

Q: Where can I purchase HEPCVIR L?

A: HEPCVIR L is available by prescription only and can be obtained at licensed pharmacies or through authorized distributors, exporters, and suppliers in India and some export markets.

Q: What is the process for storing HEPCVIR L safely?

A: Store HEPCVIR L in its original bottle below 30C, protected from moisture and light. Always keep the bottle tightly closed to maintain product quality and potency.

Q: How is HEPCVIR L beneficial for hepatitis C patients?

A: By inhibiting key viral enzymes, HEPCVIR L disrupts the hepatitis C viruss ability to replicate, leading to significant improvements in liver health and a higher chance of achieving a sustained virologic response (cure).

Tell us about your requirement